COVID-19 drug lead treatments identified
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
“Currently there are no targeted therapeutics or effective treatment options for COVID-19,” Professor Guddat said.
“In order to rapidly discover lead compounds for clinical use, we initiated a program of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus.
Professor Guddat said the project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication.
“This makes it an attractive drug target for this virus, and as people don’t naturally have this enzyme, compounds that target it are likely to have low toxicity.
“We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus.
“If the amount is small, then we have a promising compound for further studies.”
After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.
“We’re particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer,” Professor Guddat said.
“Compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.”
After the enzyme’s structure was made public, the team received more than 300 requests for more information, even before the paper was published.
“To provide an analogy, we’ve provided scientists with a fishing pole, the line and the exact bait, and have in only one month caught some fish,” Professor Guddat said.
“Now it’s up to us and the other fisherman – our fellow scientists globally – to take full advantage of this breakthrough.”
“With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future.”
The international collaboration was led by researchers at ShanghaiTech University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Biden continues to test positive for COVID-19
U.S. President Joe Biden continued to test positive for COVID-19 on Monday, White House physician Dr. Kevin O'Connor said. "This morning, as could be anticipated, his (Biden's) SARS-CoV-2 antigen ...
- San Diego Triathlete Gets Rebound COVID After Paxlovid Treatment
President Joe Biden’s recent health relapse has raised some questions about COVID-19 rebound and the medication Paxlovid.
- WA expands telehealth options to improve access to COVID treatment
Washington residents who test positive for the coronavirus can now get a free telehealth appointment for treatment consultation, regardless of their insurance coverage.
- Study suggests possible benefit from melatonin in COVID-19
A new study discusses the utility of vitamin C and melatonin as potentially therapeutic and capable of preventing acute lung injury in COVID-19.
- State expands telehealth options to improve access to COVID-19 treatment
Washington residents who test positive for COVID-19 can now get a free telehealth appointment for treatment consultation, regardless of their insurance coverage.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Fact check: No, children's COVID-19 vaccines don't contain motion-sickness drug scopolamine
Social media users have shared an article that falsely claims the military discovered scopolamine in COVID-19 vaccines formulated for children.
- Kyler Murray tested positive for COVID-19, out of camp at least most of this week
Arizona Cardinals quarterback Kyler Murray got a rest day on Saturday before the team’s off day on Sunday. He will have several more days off. According to head coach Kliff Kingsbury, Murray tested ...
- Emergent BioSolutions in ‘early innings’ of shift away from Covid-19 vaccine work
After a turbulent year, Emergent BioSolutions is taking steps to return to its pre-pandemic roadmap and leave the work directly linked to Covid in the rearview mirror.
- NorthShore University Health to pay $10.3 million in COVID-19 vaccine lawsuit
The System has agreed to pay $10.3 million in a COVID-19 vaccine lawsuit. More than a dozen health care workers sued the Evanston-based group after they were denied religious exemptions for ...
- Seahawks coach Pete Carroll tests positive for COVID-19
Seattle Seahawks coach Pete Carroll has tested positive for COVID-19, the team announced on Monday. The Seahawks issued a statement about an hour before their fifth training camp practice started. The ...